4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-22-060966
See Remarks sold 3,322 shares at $10.87 ($36,110)
- See Remarks acquired 144,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brumm Joshua T See Remarks | 2022-12-09 | Grant or award | +144,000 | 333,123 | D | ||
| Brumm Joshua T See Remarks | 2022-12-12 | Sale | −3,322 | $10.87 | $36,110 | 329,801 | D |
| Derivatives | |||||||
| Brumm Joshua T See Remarks | 2022-12-09 | Grant or award · Stock Option (right to buy) | +222,000 | 222,000 | D | ||
| Open-market sales · 3,322 sh · avg $10.87 · $36,110 | |||||||
Loading xslF345X03/doc4.xml…